Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance

Clinical trial NCT02252224 · COMPLETED

Trial details

NCT number: NCT02252224
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes Mellitus

Start date: 2014-09-23
Primary completion: 2016-11-30
Enrollment: 3123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.